Tecan
Printer friendly view

Board of Directors

The Board of Directors is responsible for the ultimate supervision and management of the Company, including the establishment of general strategies and guidelines, as well as for other matters which by law are under its non-transferable responsibility. To the extent permitted by law and except as otherwise provided in some cases in the Company's Articles of Incorporation and Organizational Regulations, the management of the Company's affairs is delegated to the Management Board pursuant to Organizational Regulations adopted by the Board of Directors.

 

 

 

 

 

 

Rolf Classon 

Chairman of the Board 
Chairman of the Nomination and Governance Committee
Since 2009, elected until 2015

1945, Swedish citizen

Chemical Engineer, Gothenburg School of Engineering
Pol. Mag., University of Gothenburg

Professional background

2005 - 2006
2002 - 2004

1995 - 2002
1991 - 1995
1990 - 1991
1984 - 1990

1979 - 1984

1974 - 1978
1969 - 1974

Hillenbrand Industries, interim President and CEO
Bayer HealthCare, CEO and Chairman of the
Executive Committee
Bayer Diagnostics, President
Bayer Diagnostics, Executive Vice President
Pharmacia Biosystems AB, President and COO
Pharmacia Development Company, Inc.,
President
Pharmacia AB Hospital Products Division,
President
Asbjorn Habberstad AB, Consultant
Pharmacia AB, Director, Organization
Development

Other activities


Auxilium Pharmaceuticals, USA, Non-executive Chairman;
Hill-Rom Holdings, USA, Non-executive Chairman;
Fresenius Medical Care AG, Germany, member of the Board.

   
 
 

Heinrich Fischer

Vice-Chairman of the Board
Chairman of the Audit Committee
Member of the Nomination and Governance Committee
Since 2007, elected until 2015

1950, Swiss citizen


Master of Applied Physics & Electrical Engineering (ETH Zurich), MBA (University of Zurich)


Professional background

since 2007

1996 - 2007

1994 - 2005

1991 - 1996

1980 - 1990

DiamondScull AG, owner and Chairman of the Board
Delegate of the Board and Chief Executive Officer Saurer Group
Co-founder and Chairman of ISE (Integrated System Engineering)
Executive Vice President, Corporate Development at Oerlikon-Bührle Group
Director of Staff Technology and Executive Vice President at Balzers Division of Oerlikon-Bührle Group

Other activities


Orell Füssli Holding AG, Chairman of the Board;
Hilti AG, member of the Board;
CAMOX Fund, member of the Board;
Sensirion Holding AG, member of the Board;
SWM Inc., Atlanta/USA, member or the Board;

     
 
     
 

Dr. Oliver Fetzer

Chairman of the Compensation Committee
Member of the Nomination and Governance Committee
Since 2011, elected until 2015
 
1964, US citizen

MBA, Carnegie Mellon University, Pittsburgh, USA
Ph.D. Pharmaceutical Sciences (Major: Medicinal Chemistry), Medical University of South Carolina, USA

 

Professional background

since 2014
2009 - 2014


2007 - 2008
2002 - 2007



1993 - 2002

CEO Synthetic Genomics
Cerulean Pharma Inc., USA,
President and Chief Executive Officer, Member of the Board of Directors
Sabbatical             
Cubist Pharmaceuticals, USA, various management positions, including Senior Vice President, Corporate Development and Research and Development
The Boston Consulting Group, USA, between 2000 and 2002 Managing Director and Partner, Boston

Other activities

Auxilium Pharmaceuticals, USA, member of the Board

     
 
 

Dr. Karen Hübscher

Member of the Audit Committee
Since 2012, elected until 2015

1963, Swiss and British citizen 

MBA (IMD Lausanne)
Ph.D. Natural Sciences, Molecular Biology (ETH Zurich)
Masters Degree, Animal Sciences (ETH Zurich)

Professional background

Since 2014
2012 - 2014

2009 - 2011




2006 - 2009



2000 - 2005

1995 - 2000

CEO Solvias AG
Founder and Managing Director of FibulaMedical AG
Novartis Vaccines & Diagnostics AG, Basel, Switzerland Head Public Health and Market Access Europe Member of the European Commercial Operations Leadership Team Site Head Novartis Vaccines & Diagnostics AG, Basel.
Novartis Vaccines & Diagnostics, Emeryville, CA, and Cambridge, MA, USA
Global Head Business Development und member of the Executive Committee and Innovation Board
Novartis, Basel, Switzerland
Global Head of Investor Relations
Novartis, Basel, Switzerland (until 1997 CIBA-Geigy)
Various positions

Other activities

none

     
 
 

Dr. Christa Kreuzburg 

Member of the Compensation Committee
Since 2013, elected until 2015

1959, German citizen

Diploma and Ph.D. in Physical Chemistry, Duisburg University, Chemical Faculty

Professional background

Since 2009

2007 - 2008


2006 - 2007



2002 - 2005



2000 - 2002

1997 - 1999

1994 - 1996

1990 - 1994

Consulting projects for small and mid-size Healthcare companies
Bayer HealthCare, Berlin, Germany
Head of Bayer Schering Pharma Europe/Canada and member of the Executive Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Primary Care / International Operations and member of the Pharma Management Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Japan (from 2004) / Europe / MERA and member of the Pharma Management Committee
Bayer AG, Leverkusen, Germany Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Departmental Head, Central Research
Bayer AG, Leverkusen, Germany
Laboratory Head, Central Research

Other activities

none

     
   
 
 

Gérard Vaillant 

Acting Chief Executive Officer (CEO) from February 2012 until October 2012
(therefore resigned as Member of the Audit Committee in April 2012)
Since 2004, elected until 2015

1942, US citizen

Degree in Marketing (École Supérieure de Commerce, Paris) and MS (University of Sciences, Paris) 

Professional background


1995 - 2004



1992 - 1995


1987 - 1992

Johnson & Johnson, Company Group Chairman Diagnostics Worldwide; Member of the Medical Devices & Diagnostics Group Operating Committee of J&J until retirement in 2004
Worldwide President LifeScan (a J&J company), and Company Group Chairman Diagnostics Worldwide
Various senior management positions within Johnson & Johnson (US), including Vice-President, J&J International

Other activities

Theradiag SA, France, member of the Board;
Safe Orthopaedics, France, Chairman of the Board;
Patho Quest S.A.S., France, Chairman of the Board;
STAT-Diagnostica & Innovation S.L.,Spain, Chairman of the Board

     
 
   

Erik Walldén

Member of the Audit Committee
Since 2011, elected until 2015

1949, Swedish citizen

Chemical Engineer, Uppsala University, Sweden

Professional background

Since 2006

2009 - 2013
2007 - 2009
2004 - 2006
1998 - 2003
1997 - 1998


1994 - 1997

1992 - 1994
1989 - 1992


1986 - 1989

1982 - 1986

1976 - 1982

1974 - 1976

Chairman and President,
WalldenAssociates (Erik Walldén AB)
Gyros AB, Sweden, CEO
CEO Affibody Holding AB
President and CEO, Biacore International AB
President and CEO, Pyrosequencing AB
Vice President, Chromatography Products, PerSeptive Biosystems (Applera Corporation), USA
Vice President, Worldwide Marketing & Support, PerSeptive Biosystems, USA
Managing Director, Cobalt Trading Relations AB; Vice President Worldwide Marketing, Sales and Support, Biosensor AB
(today Biacore International AB)
Director, Pharmacia LKB Biotechnology AB, Molecular Biology Division
Various marketing positions,
Pharmacia Biotechnology AB
Various R&D positions,
Pharmacia Biotechnology AB
Research Assistant,
Royal Institute of Technology, Stockholm

Other activities

Member of Industrial Supervisory Board of Healthinvest Partners AB;
Exiqon A/S, Deputy Chairman;
Genovis AB, Chairman of the Board;
AroCell AB, Chairman of the Board